Effect of melatonin ( a hormone for sleep induction) supplement on the quality of sleep and control of blood pressure in hemodialysis patients
Phase 2
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2024/07/069863
- Lead Sponsor
- Madras Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Maintenance hemodialysis patients who are more than 18 years
2. Dialysis vintage more than one year
3. Baseline Pittsburgh Sleep Quality Index more than 5
Exclusion Criteria
Less than 18 years, more than 65 years, with advanced liver disease, malignancy, heart failure, active infection, pregnancy, BMI more than 40, psychosis, patient on hypnotics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of oral melatonin on sleep quality, 24 hour ambulatory BP and depression scoring in maintenance hemodialysis patientsTimepoint: 3 months after oral melatonin supplementation
- Secondary Outcome Measures
Name Time Method Effect of oral melatonin on depression scoringTimepoint: 3 months supplementation